Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic Carcinoma

British Journal of Urology

Volumn 67, Issue 5, 1991, Pages 502-508

  KAISARY, A V ^a,b,c,d   TYRRELL, C J ^a,b,c,d   PEELING, W B ^a,b,c,d   GRIFFITHS, K ^a,b,c,d  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Aneurin Bevan University Health BoardClinical Research and Innovation Centre St Woolos Hospital   (United Kingdom)

^c Plymouth General Hospital   (United Kingdom)

^d Tenovus Inst for Cancer Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GOSERELIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; AGED, 80 AND OVER; BUSERELIN; COMPARATIVE STUDY; GOSERELIN; GREAT BRITAIN; HUMAN; IRELAND; MALE; ORCHIECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TESTOSTERONE;

EID: 0025828605     PISSN: 00071331     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.1991.tb15195.x     Document Type: Article

References (5)

1. Inhibition of testicular luteinising hormone‐releasing hormone agonist or human chorionic gonadotrophs
2. Prostate
3. Non‐parametric estimation from incomplete observations. /
4. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. I. Introduction and design
5. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples